Special Issue Title:

Prostate Cancer and Prostatic Diseases: etiology, diagnosis, and treatment

Deadline for manuscript submissions: 13 September 2024

Print Special Issue Flyer (13)

Special Issue Editor

  • Guest Editor

    Yipeng XuE-MailWebsite

    Department of Urology, Zhejiang Cancer Hospital, Hangzhou, China; The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

    Interests: Urinary system tumors

  • Guest Editor

    Zihao ChenE-MailWebsite

    School of Life Sciences, Technical University of Munich, Munich, Germany

    Interests: High-throughput Sequencing Data Analysis; Machine Learning Models Construction; Computer-Aided Drug Discovery; Web Server and Software Construction; Protein Function Prediction; Protein Structure Prediction, including Complete 3D Structures and Binding Sites

  • Guest Editor

    Shuai ZhuE-MailWebsite

    Department of Urology, Berlin Charité Medical University, Berlin, Germany

    Interests: Urology

Special Issue Information

Dear Colleagues,

We kindly request your contributions to our preparatory work and the subsequent publication in a special issue of "Journal of Men's Health" on the topic of prostate cancer and prostate diseases.

As the aging population continues to grow, prostate cancer (PCa) and other prostate diseases such as benign prostatic hyperplasia (BPH) and prostatitis are increasingly becoming topics of concern for family physicians and the general public. Prostatitis is a common urinary system disease in men under 40, accounting for approximately 25% to 30% of urology outpatient cases, and its incidence is on the rise. Chronic prostatitis not only affects a patient's work and quality of life but also impacts their sexual function, leading to erectile dysfunction, premature ejaculation, and even infertility. Prostatitis can also influence prostate hyperplasia to some extent, as it can damage prostate cells, trigger chronic inflammatory responses, alter prostate tissue structures, and potentially exacerbate prostate hyperplasia. Therefore, patients with both prostatitis and prostate hyperplasia may experience severe lower urinary tract symptoms and acute urinary retention. Prostate cancer is currently the most common male malignancy worldwide, making prostate health a lifelong concern for men. With the aging population, various prostate diseases pose significant threats to male life and health, and PCa, along with other prostate diseases like BPH and prostatitis, are increasingly drawing attention from family physicians and the general public. Various prostate diseases pose significant threats to male life and health.

Reportedly, smoking, dietary habits, social environments, environmental pollution, psychological issues, and more are all risk factors for urological diseases, including male reproductive system tumors. We need to further analyze potential risk factors from various angles and strive for early intervention to reduce the incidence of these diseases. Clinical diagnosis primarily relies on radiological examinations, blood markers, and the clinical experience of physicians. Both prostate hyperplasia and prostate cancer in their early stages exhibit common symptoms such as urinary difficulties, making it easy for clinicians to confuse the diseases. Nevertheless, the early stages of prostate diseases are often concealed, necessitating the development of more practical and convenient new technologies for early diagnosis and disease monitoring. Furthermore, the biological behavior of urinary system tumors differs from that of male reproductive system tumors. Some tumors can still be effectively controlled even in advanced stages, while others, once advanced, can only be managed palliatively. Surgical treatment remains the best option for early and mid-stage localized tumors. Currently, robotic surgery has further achieved the goals of minimally invasive and precision surgery. However, both robotic and traditional laparoscopic surgeries have their own advantages and disadvantages. Faced with different patients, we need to select the most cost-effective approach.

This special issue offers opportunities for discussion on the following additional topics:

- Etiology, diagnosis, and treatment of prostate cancer and prostatic diseases;

- Basic research and pathophysiological changes in prostate cancer and prostatic diseases;

- Application of robotic surgery in prostate cancer and prostatic diseases;

- Use of tumor markers in the diagnosis of prostate cancer.


Prostatitis; Prostate Hyperplasia; Prostate Cancer; Laparoscopic Surgery; Robotic Surgery; Biomarker Detection; Prostate Disease Pathophysiology

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. JOMH is an international peer-reviewed open access journal published by MRE Press. As of January 2021, JOMH will change to a monthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $2000. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time